Postoperative Adjuvant Randomised Trial Comparing Chemoendocrine Therapy, Chemotherapy and Immunotherapy for Patients with Stage II Breast Cancer: 5-year Results from The Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan

Author： Morimoto T.   Ogawa M.   Orita K.   Sugimachi K.   Toge T.   Dohi K.   Nomura Y.   Monden Y.   Ogawa N.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.2, 1996-02, pp. : 235-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status

By Nomura Yasuo   Shirouzu Mitsunori   Takayama Takahiro  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 51-60

Springer Publishing Company

Access to resources Recommend Favorite

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

By Buchholz Thomas  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 53-55

Informa Healthcare

Access to resources Recommend Favorite

Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study

By Colozza M.   Bisagni G.   Mosconi A.M.   Gori S.   Boni C.   Sabbatini R.   Frassoldati A.   Passalacqua R.   Bian A.R.   Rodino C.   Rondini E.   Algeri R.   Di Sarra S.   De Angelis V.   Cocconi G.   Tonato M.   on behalf of the Italian Oncology Group for Clinical Research GOIRC  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2279-2288

Elsevier

Access to resources Recommend Favorite

Adjuvant Therapy of Breast Cancer

By Kaklamani Virginia   Gradishar William  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 548-560

Informa Healthcare

Access to resources Recommend Favorite

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

By Purmonen Timo T.   Päänkäälääinen Emma   Turunen Juha H. O.   Asseburg Christian   Martikainen Janne A.  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 344-352

Informa Healthcare

Access to resources Recommend Favorite